Boehringer Ingelheim Pty Ltd is a foreign owned, private company that derives its revenue from importing, exporting, marketing and retailing pharmaceuticals, chemical and animal health products. The company employs approximately 360 staff and is administered from its head office in North Ryde, New South Wales. 

Boehringer Ingelheim Pty Ltd is a wholly owned subsidiary of a Germany-based pharmaceutical company, C H Boehringer Sohn AG & Co KG. 

Boehringer Ingelheim is primarily involved with researching, developing, manufacturing and marketing pharmaceutical, chemical and animal health products.

The company focuses on the following areas:

  • Cardiometabolic
  • Central Nervous System
  • Immunology and Respiratory
  • Oncology

Boehringer Ingelheim also owns and operates several farms that grow Duboisia, from which alkaloids are extracted and used in products.

Learn more about our Company Reports

IBISWorld Company Profile Reports

Company profile reports provide key information on the Top 2000 earning companies in Australia. Reports include a written description of a company, its history, brands and products, contact details and key personnel, operating and legal structure, financial data, industries of involvement and business service providers.

Sample Data

Table of Contents

Company Details
Key Personnel
Growth & Ratios
Service Providers

Looking for our Industry reports?

Assess your competitors with powerful business tools that provide strategic insights and analysis on over 600 Australian industries.

Contact Us

Want to speak to a representative? Call us.